Seeking AlphaWed, 03 Jun 2026 20:02:16 GMTExelixis, Inc. (EXEL) Presents at Jefferies Global Healthcare Conference 2026 TranscriptEXEL+6.30%
Zacks Investment ResearchWed, 03 Jun 2026 14:40:37 GMTWhy Exelixis (EXEL) is a Top Value Stock for the Long-TermEXEL+6.30%
Zacks Investment ResearchMon, 01 Jun 2026 14:51:19 GMTWhy Exelixis (EXEL) is a Top Momentum Stock for the Long-TermEXEL+6.30%
24/7 Wall StreetThu, 28 May 2026 14:23:13 GMTIf Decades of History Tell Us Anything, This Biotech Near $50 Is Primed to SkyrocketEXEL+6.30%
Seeking AlphaThu, 28 May 2026 07:00:24 GMTExelixis, Inc. (EXEL) Presents at Bernstein 42nd Annual Strategic Decisions Conference TranscriptEXEL+6.30%
Seeking AlphaSat, 23 May 2026 21:26:09 GMTExelixis: Financial Performance Improves Faster Than Market ExpectationsEXEL+6.30%
MarketBeatSat, 23 May 2026 09:04:21 GMTExelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch NearEXEL+6.30%
Seeking AlphaWed, 20 May 2026 20:00:54 GMTExelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum TranscriptEXEL+6.30%
Seeking AlphaTue, 19 May 2026 15:00:50 GMTExelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptEXEL+6.30%
Zacks Investment ResearchFri, 15 May 2026 14:51:27 GMTExelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?EXEL+6.30%
Seeking AlphaTue, 12 May 2026 19:01:03 GMTExelixis, Inc. (EXEL) Presents at Bank of America Global Healthcare Conference 2026 TranscriptEXEL+6.30%
Zacks Investment ResearchWed, 06 May 2026 17:01:23 GMTEXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in FocusEXEL+6.30%
Zacks Investment ResearchWed, 06 May 2026 14:41:26 GMTHere's Why Exelixis (EXEL) is a Strong Value StockEXEL+6.30%
Seeking AlphaWed, 06 May 2026 07:31:36 GMTExelixis, Inc. (EXEL) Q1 2026 Earnings Call TranscriptEXEL+6.30%
Zacks Investment ResearchTue, 05 May 2026 22:30:26 GMTExelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesEXEL+6.30%
Zacks Investment ResearchTue, 05 May 2026 22:16:20 GMTExelixis (EXEL) Tops Q1 Earnings EstimatesEXEL+6.30%
Zacks Investment ResearchMon, 04 May 2026 14:46:17 GMTHere's Why Exelixis (EXEL) is a Strong Growth StockEXEL+6.30%
Zacks Investment ResearchTue, 28 Apr 2026 15:08:54 GMTExelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseEXEL+6.30%
Zacks Investment ResearchMon, 20 Apr 2026 14:42:44 GMTWhy Exelixis (EXEL) is a Top Value Stock for the Long-TermEXEL+6.30%